Trials & Tribulations Earlier diagnosis, better outcomes: Telemedicine has found a home in oncology September 26, 2025Vol.51 No.35By Hardeep Phull
Conversation with The Cancer Letter Will MCD tests revolutionize cancer screening? NCI begins enrollment in Vanguard “feasibility” trial to start finding out July 25, 2025Vol.51 No.29By Sara Willa Ernst, Jacquelyn Cobb and Paul Goldberg
First-ever financial toxicity tumor board aims to change the standard of careResearchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI July 11, 2025Vol.51 No.27By Claire Marie Porter
Trials & Tribulations An overlooked immune cell population may offer new direction for cell and gene therapy July 11, 2025Vol.51 No.27By Arthur Machlenkin
She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research July 03, 2025Vol.51 No.26By Jacquelyn Cobb
How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest June 27, 2025Vol.51 No.25By Paul Goldberg
Trials & Tribulations As cancer patients use AI chatbots, dangers lurk—but new safeguards can help June 27, 2025Vol.51 No.25By Ghulam Rasool, Brian D. Gonzalez and Katherine Chung-Bridges
Trials & Tribulations Optimizing dosing of expensive and toxic oncology drugs: Making America healthier June 20, 2025Vol.51 No.24By Mark J. Ratain, David A. Hyman, Jill E. Feldman, Beth R. Jacobson and Allen S. Lichter
CRC patients with cannabis use disorder may have higher odds of death within five years of diagnosisObservational study suggests that clinicians should be cautious when recommending cannabis to manage cancer symptoms June 13, 2025Vol.51 No.23By Jacquelyn Cobb
Free Young women are now diagnosed with cancer at twice the rate of young menThe face of cancer is changing at a time when research is plagued by existential threats June 06, 2025Vol.51 No.22By Claire Marie Porter
